Drugs of Today
Latest Publications

TOTAL DOCUMENTS

1350

(FIVE YEARS 202)

H-INDEX

35

(FIVE YEARS 7)

Published By Clarivate Analytics (US)

1699-3993

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

New product intros [ciprofol, EpiVacCorona, imlifidase (first-in-class), melphalan flufenamide hydrochloride]

Drugs of Today ◽

10.1358/dot.2021.57.5.3310148 ◽

2021 ◽

Vol 57 (5) ◽

pp. 359

Keyword(s):

Download Full-text

New product intros [coblopasvir dihydrochloride, dasiglucagon, 2-deoxyglucose, estetrol/drospirenone (new combination), risperidone microspheres (new formulation), SaNOtize nitric oxide nasal spray (NONS), tocilizumab (new indication)]

Drugs of Today ◽

10.1358/dot.2021.57.8.3341558 ◽

2021 ◽

Vol 57 (8) ◽

pp. 527

Keyword(s):

Nitric Oxide ◽

Nasal Spray ◽

New Product ◽

New Combination ◽

New Formulation

Download Full-text

Atoltivimab/maftivimab/odesivimab (Inmazeb) combination to treat infection caused by Zaire ebolavirus

Drugs of Today ◽

10.1358/dot.2021.57.8.3280599 ◽

2021 ◽

Vol 57 (8) ◽

pp. 483

Author(s):

D. Saxena ◽

G. Kaul ◽

A. Dasgupta ◽

S. Chopra

Keyword(s):

Zaire Ebolavirus

Download Full-text

Vibegron: a beta3-adrenergic agonist for the treatment of overactive bladder

Drugs of Today ◽

10.1358/dot.2021.57.8.3293588 ◽

2021 ◽

Vol 57 (8) ◽

pp. 507

Author(s):

D.M. Paton

Keyword(s):

Overactive Bladder ◽

Adrenergic Agonist

Download Full-text

An update on atezolizumab for hepatocellular carcinoma

Drugs of Today ◽

10.1358/dot.2021.57.6.3264116 ◽

2021 ◽

Vol 57 (6) ◽

pp. 365

Author(s):

l. Ielasi ◽

V. Sansone ◽

A. Forgione ◽

A. Granito ◽

F. Benevento ◽

...

Keyword(s):

Hepatocellular Carcinoma

Download Full-text

Dostarlimab for the treatment of endometrium cancer and other solid tumors

Drugs of Today ◽

10.1358/dot.2021.57.3.3233363 ◽

2021 ◽

Vol 57 (3) ◽

pp. 187

Author(s):

J. Rubio-Perez ◽

R. Hernandez ◽

T. Hernandez ◽

B. Doger ◽

V. Casado ◽

...

Keyword(s):

Download Full-text

New product intros [berotralstat hydrochloride, cetuximab sarotalocan, daratumumab sc (new indication), eptacog beta, coagulation factor VIIa-jncw, etesevimab, evinacumab-dgnb (first-in-class), human SARS-CoV-2 inactivated vaccine, inclisiran, orelabrutinib, relugolix (new indication), remogliflozin etabonate/vildagliptin (new combination), surufatinib, voclosporin]

Drugs of Today ◽

10.1358/dot.2021.57.3.3285930 ◽

2021 ◽

Vol 57 (3) ◽

pp. 241

Keyword(s):

Factor Viia ◽

Coagulation Factor ◽

New Product ◽

New Combination ◽

Inactivated Vaccine ◽

Remogliflozin Etabonate

Download Full-text

Inebilizumab in AQP4-Ab-positive neuromyelitis optica spectrum disorder

Drugs of Today ◽

10.1358/dot.2021.57.5.3265453 ◽

2021 ◽

Vol 57 (5) ◽

pp. 321

Author(s):

N. Siebert ◽

A. Duchow ◽

F. Paul ◽

C. Infante-Duarte ◽

J. Bellmann-Strobl

Keyword(s):

Neuromyelitis Optica ◽

Spectrum Disorder ◽

Neuromyelitis Optica Spectrum Disorder

Download Full-text

Bulevirtide for HBV and HDV infections

Drugs of Today ◽

10.1358/dot.2021.57.7.3283861 ◽

2021 ◽

Vol 57 (7) ◽

pp. 433

Author(s):

D. Yardeni ◽

C. Koh

Download Full-text

Clinical development and current role of margetuximab for the treatment of breast cancer

Drugs of Today ◽

10.1358/dot.2021.57.9.3319148 ◽

2021 ◽

Vol 57 (9) ◽

pp. 551

Author(s):

P. Tarantino ◽

J. Uliano ◽

S. Morganti ◽

F. Giugliano ◽

E. Crimini ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Development ◽

Download Full-text